JPS63104909A - Skin protecting agent - Google Patents

Skin protecting agent

Info

Publication number
JPS63104909A
JPS63104909A JP61253071A JP25307186A JPS63104909A JP S63104909 A JPS63104909 A JP S63104909A JP 61253071 A JP61253071 A JP 61253071A JP 25307186 A JP25307186 A JP 25307186A JP S63104909 A JPS63104909 A JP S63104909A
Authority
JP
Japan
Prior art keywords
weight
skin
polymer
parts
maa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61253071A
Other languages
Japanese (ja)
Other versions
JPH029006B2 (en
Inventor
Izumi Saito
泉 斎藤
Shigeru Kido
茂 木戸
Yoshio Sasaki
佐々木 義雄
Hideichiro Shinohara
秀一郎 篠原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissin Chemical Industry Co Ltd
Shionogi and Co Ltd
Original Assignee
Nissin Chemical Industry Co Ltd
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Chemical Industry Co Ltd, Shionogi and Co Ltd filed Critical Nissin Chemical Industry Co Ltd
Priority to JP61253071A priority Critical patent/JPS63104909A/en
Priority to CA000548194A priority patent/CA1299319C/en
Priority to NZ222096A priority patent/NZ222096A/en
Priority to US07/109,619 priority patent/US4874830A/en
Priority to DE8787309265T priority patent/DE3779250D1/en
Priority to EP19870309265 priority patent/EP0265228B1/en
Priority to AT87309265T priority patent/ATE76286T1/en
Priority to ES198787309265T priority patent/ES2031909T3/en
Priority to KR1019870011752A priority patent/KR950011449B1/en
Priority to AU80088/87A priority patent/AU602731B2/en
Publication of JPS63104909A publication Critical patent/JPS63104909A/en
Priority to US07/353,818 priority patent/US4914140A/en
Publication of JPH029006B2 publication Critical patent/JPH029006B2/ja
Priority to GR920401234T priority patent/GR3004890T3/el
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/12Esters of monohydric alcohols or phenols
    • C08F220/16Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C08F220/1802C2-(meth)acrylate, e.g. ethyl (meth)acrylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain a protecting agent forming a flexible, thin film having excellent water resistance and elongation, not providing the skin with a feeling of physical disorder, by dissolving specific amounts of a specific acrylic polymer and cellulose derivative in a hydrous alcohol. CONSTITUTION:(A) 2-10wt%, preferably 4-7wt% acrylic polymer (preferably 100,000-1,300,000 weight-average molecular weight) having a monomer weight ratio of ethyl acrylate and methacrylic acid of 75/25-95/5, preferably 80/20-90.10, <=50ppm residual monomers and substantially containing no surface active agent and (B) 0.3-2wt%, preferably 0.7-1.5wt% cellulose derivative, preferably ethyl cellulose are dissolved in a hydrous alcohol. The protecting agent has low irritation, a coating film formed protects a neutral detergent from permeating and can be readily removed with a weakly alkali solution of soap, etc., or an alcohol, etc., after use.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、耐水性があり、しかもアルカリ可溶性で不純
物の少ないアクリル系ポリマーを主体とする皮膚保護剤
に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a skin protective agent that is water resistant, alkali soluble, and contains little impurities, and is mainly comprised of an acrylic polymer.

[従来の技術] 皮膚を化学薬品やその他刺激性物質などから守る為の保
護被覆剤が知られている。これは皮膚表面に塗布するこ
とにより、被膜を形成し、もって皮膚の保護を図るもの
である。
[Prior Art] Protective coatings for protecting the skin from chemicals and other irritating substances are known. When applied to the skin surface, it forms a film to protect the skin.

古くはアセトン、酢酸エチルのような強力な有機溶媒に
溶解されたセルロース誘導体が使用きれて来たが、有機
溶媒が皮膚、粘膜などを刺激したり、形成された被膜を
皮膚から除去することが容易でないなどの問題があった
In the past, cellulose derivatives dissolved in strong organic solvents such as acetone and ethyl acetate have been used, but organic solvents can irritate the skin and mucous membranes, and can remove the film formed from the skin. There were problems such as it was not easy.

最近でも、米国でn−ブチルポリエステル/マレイン酸
および可塑化されたエチルセルロースを主成分とする皮
膚保護剤(以下、該先行技術保護剤と言うこともある)
が市販きれているが、これは日本国内では、未だ安全性
が確立されていない等、使用上に問題があり、実用化さ
れていない。
Recently, a skin protective agent (hereinafter also referred to as the prior art protective agent) mainly composed of n-butyl polyester/maleic acid and plasticized ethyl cellulose has been developed in the United States.
Although it is commercially available, it has not been put into practical use in Japan because its safety has not yet been established and there are problems with its use.

この該先行技術保護剤では、体外カテーテル、固定テー
プ、ギプス、オムツなどと皮膚との間に保護膜をつくる
。あるいは、グリースで手が汚れるのを助ぐことなどの
用途を提案している。
This prior art protective agent creates a protective film between the skin and an extracorporeal catheter, fixation tape, cast, diaper, etc. Another proposed use is to help keep hands from getting dirty with grease.

本発明者等は特に、中性洗剤を使用する家庭主婦、レス
トラン、病院、美容院などにおける器具洗浄者の皮膚を
被覆しうるポリマーを鋭意検討した。アクリル系ポリマ
ーは、従来から医薬などの使用実績もあり、安全性の高
いことも知られている。然し乍ら、公知のアクリル系ポ
リマーは何れも溶液重合法や乳化重合法などの慣習重合
法によって製造されている為、生成ポリマー中にアニオ
ン界面活性剤、連鎖移動剤、残存モノマーなどを多く含
んでいる。従って、皮膚刺激性があったり、環境保全上
の問題があるのみならず、界面活性剤が存在すると被膜
が脆くなったり、耐水性が劣ったりするので、中性洗剤
の不透過などを主目的とする本発明には不適であった。
In particular, the present inventors have conducted intensive studies on polymers that can coat the skin of housewives who use neutral detergents, and those who clean equipment in restaurants, hospitals, beauty salons, and the like. Acrylic polymers have long been used in medicine and are known to be highly safe. However, since all known acrylic polymers are manufactured by conventional polymerization methods such as solution polymerization and emulsion polymerization, the resulting polymers contain large amounts of anionic surfactants, chain transfer agents, residual monomers, etc. . Therefore, not only is it irritating to the skin and poses problems in terms of environmental protection, but the presence of surfactants also makes the film brittle and has poor water resistance, so the main purpose is to impermeate neutral detergents. This was not suitable for the present invention.

又、一部では界面活性剤及びそれに類する水溶性物質を
使用しないポリマーエマルジョン合成の研究も行なわれ
て来たが、例えばアクリル酸エチルとアクリル酸の共重
合にこの方法を利用した場合、アクリル酸の量が2〜3
モル%を超すと、生成ポリマーエマルジョンは機械的に
不安定になり、ゲル化を起こしやすいときれて来た(松
本ら:高分子論文集32巻、9号、1975)。
In addition, some research has been conducted on polymer emulsion synthesis that does not use surfactants or similar water-soluble substances, but for example, when this method is used to copolymerize ethyl acrylate and acrylic acid, The amount of
When the amount exceeds mol %, the resulting polymer emulsion becomes mechanically unstable and tends to gel (Matsumoto et al., Kobunshi Ronsen Vol. 32, No. 9, 1975).

更に、医薬用に知られている既知のアクリル系ポリマー
、例えば、西ドイツ国ロームファーマ社(R6hm P
harma )のオイドラギッドなどでは生成フィルム
の伸び、抗張力などの点からも本発明目的の用途には不
向きであることが1判明した。
Furthermore, known acrylic polymers known for pharmaceutical use, such as those manufactured by Rohm Pharma, West Germany (R6hm P
It has been found that Eudragid (Pharma) is unsuitable for the purpose of the present invention due to the elongation and tensile strength of the produced film.

[発明が解決しようとする問題点コ 本発明目的を達成するにi±1、以下の諸点をバランス
良く満足させることが必要となるが、これらを同時に満
足させるポリマーは現在のところ開発されていない0本
発明が目的とする皮膚保護剤の要求性能としては 1) 薄い被膜を形成できること、 2)耐水性があって、アルカリ可溶性であること、 3)伸びのある柔軟なフィルムをつくり、皮膚に密着す
ること、 4〉 残存モノマーなどの不純物が少なく、臭い及び刺
激性のないこと、 5〉 中性洗剤を透過しないこと、 6) アルコール又は含水アルコールに溶解すること、
及び 7)通気性及び透湿性があって、被覆時に蒸れず、べと
つかないこと、 などである。
[Problems to be Solved by the Invention] In order to achieve the purpose of the present invention, it is necessary to satisfy the following points in a well-balanced manner, but no polymer has been developed that satisfies them at the same time. 0 The required performance of the skin protective agent targeted by the present invention is 1) to be able to form a thin film, 2) to be water resistant and alkali soluble, and 3) to be able to form a stretchable and flexible film that does not adhere to the skin. 4) Low impurities such as residual monomers, no odor or irritation, 5) Impermeable to neutral detergents, 6) Soluble in alcohol or water-containing alcohol,
and 7) it has air permeability and moisture permeability, and does not get stuffy or sticky when covered.

[問題点を解決する為の手段] 本発明者等は以上の点に鑑み、アクリル酸エチル(以下
、EAと言うこともある)75重量部〜95重量部とメ
タアクリル酸(以下、MAAと言うこともある)25重
量部〜5重量部のモノマーを脱イオン水中、加熱下で、
過硫酸塩を重合開始剤として使用し、所望により更に過
酸化水素、硫酸第一鉄およびL−アスコルビン酸などの
酸化還元触媒系を単独または組合わせて使用し、後処理
すれば、本発明目的にかなった好ましいポリマーが合成
されることを見出し、本発明を完成させた0本発明皮膚
保護剤に使用するコポリマーのモノマーユニットについ
て、更に詳しく説明する。
[Means for Solving the Problems] In view of the above points, the present inventors added 75 to 95 parts by weight of ethyl acrylate (hereinafter also referred to as EA) and methacrylic acid (hereinafter referred to as MAA). 25 parts by weight to 5 parts by weight of the monomer in deionized water under heat,
The use of a persulfate as a polymerization initiator, optionally with further use of a redox catalyst system such as hydrogen peroxide, ferrous sulfate and L-ascorbic acid, alone or in combination, and post-treatment achieves the objectives of the present invention. We have now completed the present invention by discovering that a suitable polymer can be synthesized according to the present invention.The monomer units of the copolymer used in the skin protection agent of the present invention will be explained in more detail.

アクリル酸エチルはコポリマー中において75〜95重
量部となる範囲で、好ましくは80〜90重量部となる
範囲で使用する。EAを選んだ理由は、EAの使用によ
って、合成コポリマーがアルコール又は含水アルコール
などの溶媒に溶解しやすくするためである。
Ethyl acrylate is used in an amount of 75 to 95 parts by weight, preferably 80 to 90 parts by weight in the copolymer. EA was chosen because its use makes the synthetic copolymer more soluble in solvents such as alcohol or hydroalcohol.

メタアクリル酸はコポリマー中に25〜5重量部となる
範囲で、好ましくは20〜10重量部となる範囲で使用
する。MAAの組成比が前記下限以下では、アルカリ可
溶性が不十分となり、MAAの組成比が前記上限以上で
は、伸びや柔軟性が低下し好ましくない、MAAの組成
比が35重量部を超える場合には、ポリマーが不安定に
なり、その安定化に乳化剤や懸濁剤が必要になる0本発
明組成から得たフィルムの耐水性は、該先行技術保護剤
のそれより良好であった。
Methacrylic acid is used in the copolymer in an amount of 25 to 5 parts by weight, preferably 20 to 10 parts by weight. If the composition ratio of MAA is below the above-mentioned lower limit, the alkali solubility will be insufficient, and if the composition ratio of MAA is above the above-mentioned upper limit, elongation and flexibility will decrease, which is undesirable.If the composition ratio of MAA exceeds 35 parts by weight, The water resistance of the films obtained from the compositions of the present invention was better than that of the prior art protectants.

アクリル酸の代わりに、MAAを選んだ理由はMAAの
方が安全性が高いと言われており、耐水性、残存モノマ
ー減少にも優きっていることが判明したからである。ま
た、EAとのコポリマーを乳化剤の不存在下で作る場合
、アクリル酸を相手に選ぶより、MAAを相手に選ぶ方
が不飽和カルボン酸モノマーを高い比率で使用しうろこ
とを見出したこともMAA選定の有力な理由である。こ
の結果、不純物の少ない、より安全なアクリル系ポリマ
ーを得ることが出来た。既知の該先行技術保護剤と比較
して、本発明皮膚保護剤では違和感、ツッパリ感のない
、より良好な感触を持つ保護膜を与える。
The reason for choosing MAA instead of acrylic acid is that MAA is said to be safer and has been found to be superior in terms of water resistance and reduction of residual monomers. Furthermore, when making a copolymer with EA in the absence of an emulsifier, MAA was found to be more effective at using a higher proportion of unsaturated carboxylic acid monomers than when using acrylic acid as a copolymer. This is a strong reason for selection. As a result, a safer acrylic polymer with fewer impurities could be obtained. Compared to the known prior art protective agents, the skin protective agent of the present invention provides a protective film with a better feel without any discomfort or tightness.

前記の皮膚保護剤用ポリマーとして要求される諸性能も
アクリル系ポリマー中のアクリル酸エチルとメタアクリ
ル酸のモノマー組成比率を変えることによって調節する
ことがでる0例えば、耐水性を重視したフィルムを意図
する時には、MAA組成比を低くし、アルカリ可溶性を
重視したフィルムを意図する時には、MAA組成比を高
くすればよい。
The various performances required for the above-mentioned polymers for skin protection agents can also be adjusted by changing the monomer composition ratio of ethyl acrylate and methacrylic acid in the acrylic polymer. When desired, the MAA composition ratio may be lowered, and when a film with emphasis on alkali solubility is intended, the MAA composition ratio may be increased.

本発明のアクリル系ポリマーの一般的製造法を示す、脱
イオン水を窒素置換した密閉型反応器に入れて加熱する
。予め脱イオン水に溶解した過硫酸塩を重合開始剤とし
て加え、次いでEA及びMAAのそれぞれのモノマーを
攪拌下で所定時間かけて添加する0重合は進行し、モノ
マー添加終了時には重合は殆ど完了している。モノマー
濃度を更に低減させたければ、該反応温度をそのまま維
持するか、または更に昇温して攪拌を続ける(以下、こ
の工程を後処理と言うこともある)。反応液を冷却して
目的のポリマーを分散液として得る。
Deionized water is placed in a closed reactor purged with nitrogen and heated, showing a general method for producing the acrylic polymer of the present invention. A persulfate dissolved in deionized water in advance is added as a polymerization initiator, and then the respective monomers of EA and MAA are added over a predetermined period of time under stirring. The polymerization proceeds, and the polymerization is almost complete by the time the monomer addition is finished. ing. If it is desired to further reduce the monomer concentration, the reaction temperature is maintained as it is, or the temperature is raised further and stirring is continued (hereinafter, this step may be referred to as post-treatment). The reaction solution is cooled to obtain the desired polymer as a dispersion.

過硫酸塩としては過硫酸アンモニウム、過硫酸ナトリウ
ム、過硫酸カリウムなどが例示され、一時に全量を添加
しても、分割あるいは連続して添加しても良い、該過硫
酸塩の使用量は、最終ポリマー濃度、重合温度、重合時
間などによって最適な量を選択するが、一般には、モノ
マー100重量部に対して約0.2〜4重量部、より好
ましくは約0.4〜3重量部用いる。下限以下では、ポ
リマー分散液の安定性不良や残存モノマーの増加を来し
、上限以上では、被膜の耐水性が低下する。 後処理に
要する時間を短縮したければ、後処理の温度を上げるか
、後処理中に過硫酸塩を追加したり、あるいは過酸化水
素、硫酸第一鉄およびL−アスコルビン酸の組合わせの
ような酸化還元触媒等を少量追加すれば良い、単に、重
合完結、残存モノマー減少だけが目的ならば、前記以外
の重合開始剤や酸化還元触媒も使用しうるが、本発明が
目的とする皮膚への適用を考慮すれば、好ましくない。
Examples of persulfates include ammonium persulfate, sodium persulfate, potassium persulfate, etc., and the total amount may be added at once, or may be added in portions or continuously.The amount of persulfate to be used depends on the final The optimum amount is selected depending on the polymer concentration, polymerization temperature, polymerization time, etc., but it is generally used in an amount of about 0.2 to 4 parts by weight, more preferably about 0.4 to 3 parts by weight, based on 100 parts by weight of the monomer. Below the lower limit, the stability of the polymer dispersion becomes poor and residual monomer increases, while above the upper limit, the water resistance of the coating decreases. If you want to reduce the time required for post-treatment, you can increase the post-treatment temperature, add persulfate during post-treatment, or use a combination of hydrogen peroxide, ferrous sulfate and L-ascorbic acid. It is sufficient to add a small amount of redox catalyst, etc. If the purpose is simply to complete the polymerization and reduce the residual monomer, polymerization initiators and redox catalysts other than those mentioned above may also be used, but they do not affect the skin that is the purpose of the present invention. This is not desirable considering the application of

モノマーはEAとMAAとを別々に添加しても良いが、
混合して添加する方が簡便である。添加速度は変化して
も良いが、一定速度で添加すれば粗大粒子の生成を妨止
できたり、温度調節も容易になり好ましい。
As monomers, EA and MAA may be added separately, but
It is easier to mix and add. Although the rate of addition may vary, it is preferable to add at a constant rate because it prevents the formation of coarse particles and facilitates temperature control.

重合温度は約45〜98℃、より好ましくは65〜95
℃の範囲に調節する。下限以下では粗大粒子が生成しや
すくなる。
The polymerization temperature is about 45-98°C, more preferably 65-95°C.
Adjust to a range of ℃. Below the lower limit, coarse particles are likely to be generated.

分散液中のポリマー濃度は特に限定きれるべきではない
が、好ましくは15〜65%、更に好ましくは25〜5
5%である。下限以下では、対モノマー過硫酸塩必要量
が増加したり、残存モノマーの相対量が増加する。また
、上限以上では、ポリマー分散液が不安定になり、粗大
粒子や器壁付着物が増加する。
Although the polymer concentration in the dispersion liquid should not be particularly limited, it is preferably 15 to 65%, more preferably 25 to 5%.
It is 5%. Below the lower limit, the amount of monomer persulfate required increases or the relative amount of residual monomer increases. Moreover, if it exceeds the upper limit, the polymer dispersion becomes unstable, and coarse particles and deposits on the vessel wall increase.

以上の方法に従えば、様々な重合度のポリマーが得られ
る。ポリマーの重量平均分子量をとくに限定する必要は
ないが、本発明目的には約10万〜200万、更に好ま
しくは約10万〜130万のものが好ましく使用される
。過硫酸塩の使用量、重合温度、ポリマー濃度を調節す
ることにより、生成ポリマーの分子量を自由に選択でき
る。
According to the above method, polymers with various degrees of polymerization can be obtained. Although it is not necessary to particularly limit the weight average molecular weight of the polymer, for the purpose of the present invention, a weight average molecular weight of about 100,000 to 2,000,000, more preferably about 100,000 to 1,300,000 is preferably used. By adjusting the amount of persulfate used, polymerization temperature, and polymer concentration, the molecular weight of the produced polymer can be freely selected.

また、エタノールやイソプロパツールなどのアルコール
を連鎖移動剤として使用すれば、分子量を低下できる。
Furthermore, if alcohol such as ethanol or isopropanol is used as a chain transfer agent, the molecular weight can be reduced.

有機硫黄化合物等、通常用いられる連鎖移動剤の使用は
、皮膚への安全性を考慮すれば好ましくない。
The use of commonly used chain transfer agents such as organic sulfur compounds is not preferred in view of skin safety.

本発明皮膚保護剤はアクリル系ポリマーおよび親水性セ
ルロースを適当な媒体に溶解して調製される。媒体とし
てはアルコール系溶媒が好ましい、エタノール又は含水
エタノールは、安全性の点からも皮膚保護剤として最も
望ましい溶解媒体であるが、エタノール含量が高いと蒸
発が速く、皮膚に傷がある時は刺激するなどの問題があ
る。
The skin protection agent of the present invention is prepared by dissolving the acrylic polymer and hydrophilic cellulose in a suitable medium. Alcohol-based solvents are preferred as the vehicle.Ethanol or aqueous ethanol is the most desirable dissolution medium for skin protection agents from the standpoint of safety, but high ethanol content evaporates quickly and may irritate the skin when there is a wound. There are problems such as

逆に、水が多過ぎるとポリマーの溶解性が低下したり、
蒸発速度が遅くなる。エタノールの代わりにイソプロパ
ノールも使用することが出来る。好ましい混合比率はア
ルコール/水の比で60/40から80/20である。
Conversely, too much water may reduce the solubility of the polymer,
Evaporation rate slows down. Isopropanol can also be used instead of ethanol. A preferred mixing ratio is 60/40 to 80/20 alcohol/water.

これらの溶媒中にアクリル系ポリマーを約2〜10%、
更に好ましくは約4〜7%の濃度で溶解するのが望まし
い、上限以上では使用時にツッパリ感がしたり、皮膚へ
の接着性が低下する。下限以下では、薄い被膜しか形成
されず、被膜が脆くなり好ましくない。
Approximately 2 to 10% of acrylic polymer in these solvents,
More preferably, it is dissolved at a concentration of about 4 to 7%; if the concentration is above the upper limit, a stiff feeling may be felt during use, and the adhesion to the skin may be reduced. Below the lower limit, only a thin film is formed and the film becomes brittle, which is not preferable.

本発明において使用するセルロース誘導体としては、例
えば、メチルセルロース、エチルセルロース、ヒドロキ
シプロピルセルロースなどが例示される。中でもエチル
セルロースが最も好ましく使用される。これらセルロー
スの添加量は約0.3%〜2%、更に好ましくは約0.
7〜1゜5%である。上限以上では形成される被膜が脆
くなり好ましくない、また、下限以下では、乾燥中にネ
バネバ感がするのでやはり好ましくない、これらセルロ
ースの添加によって、塗布時の粘着性および乾燥後の伸
縮性が著しく改善された。
Examples of cellulose derivatives used in the present invention include methylcellulose, ethylcellulose, and hydroxypropylcellulose. Among them, ethylcellulose is most preferably used. The amount of cellulose added is about 0.3% to 2%, more preferably about 0.3% to 2%.
It is 7-1°5%. Above the upper limit, the film formed becomes brittle, which is undesirable; below the lower limit, it becomes sticky during drying, which is also undesirable. The addition of these celluloses significantly increases the tackiness during application and the elasticity after drying. Improved.

本発明の皮膚保護剤には、所望ならば、適当な柔軟化剤
や、ポリビニルピロリドンなどの添加剤、防腐剤や着色
剤あるいは医薬活性成分を適宜配合しても良い。本発明
の皮膚保護剤は、無色透明の薄い被膜を形成するので、
美容上非常に好ましい、しかし、使用目的によっては適
当な着色剤を添加して、被膜形成の有無を確認しうる様
に設計しても良い。
If desired, the skin protective agent of the present invention may contain appropriate softeners, additives such as polyvinylpyrrolidone, preservatives, coloring agents, or pharmaceutically active ingredients. The skin protective agent of the present invention forms a colorless and transparent thin film, so
This is very desirable from a cosmetic point of view, but depending on the purpose of use, a suitable coloring agent may be added to the product so that the presence or absence of film formation can be confirmed.

本発明において、皮膚保護剤の製剤包装形態は特に制限
されるべきではない。該保護剤はアルコールの溶液であ
るため、アルコールの揮発を防止しうる密閉容器が好ま
しい0例えば、ガラス製やプラスチック製の瓶でも良い
し、スプレー容器でも良い。
In the present invention, the formulation packaging form of the skin protective agent should not be particularly limited. Since the protective agent is an alcohol solution, a closed container that can prevent the alcohol from volatilizing is preferable.For example, a glass or plastic bottle may be used, or a spray container may be used.

本発明で使用するアクリル系ポリマーが具備する利点、
及びポリマーを製造する上での利点を以下に要約する。
Advantages of the acrylic polymer used in the present invention,
The advantages for producing polymers and polymers are summarized below.

■ 中性洗剤を殆ど透過せず、弱アルカリ性の石麺など
で容易に洗いおとせるフィルムを形成する。
■ Forms a film that is virtually impermeable to neutral detergents and can be easily washed off with mildly alkaline stone noodles.

■ 伸びが良く、薄くかつ柔軟性の高いフィルムを形成
する。
■ Forms a thin, highly flexible film with good elongation.

■ 残存モノマーが50ppm以下の時は臭いが殆どな
くなり、刺激性もなくなる0通常の乳化重合法では残存
モノマーが多く、従って臭いも強い、この残存モノマー
低減の為には、真空吸引、重合時間の延長などの後処理
に長時間を要する。しかし、本発明で示す重合法では残
存モノマーが少ないので、後処理も容易である。
■ When the residual monomer is 50 ppm or less, there is almost no odor and no irritation. In normal emulsion polymerization, there is a lot of residual monomer, and therefore the odor is strong. To reduce this residual monomer, vacuum suction and shortening of the polymerization time are necessary. Post-processing such as extension takes a long time. However, in the polymerization method shown in the present invention, since there is little residual monomer, post-treatment is also easy.

■ 常温で安定であり、乳化剤や懸濁剤を使用せずに長
期保存可能である。
■ Stable at room temperature and can be stored for long periods without using emulsifiers or suspending agents.

以下の諸実施例等によって、本発明をより詳しく説明す
るが、これらは本発明の範囲を何ら限定するものではな
い。
The present invention will be explained in more detail with reference to the following Examples, but these are not intended to limit the scope of the present invention in any way.

参考例(ポリマーの製造) 参考例 1 窒素置換した攪拌機付密閉型反応容器に、脱イオン水2
36.1重量部を仕込んで反応器内を80°Cに調節し
たのち過硫酸アンモニウム1.2重量部を添加し、つい
で下記のモノマー混合物EA     85重量部 MAA    15重量部 を8時間にわたって添加した0反応器内を80℃に維持
したまま更に8時間攪拌を続は反応を完結させた。この
分散液の固形分は30%で、ガスクロマトグラフィーに
よる残存モノマーの分析の結果、EAは37ppmでM
AAは10ppm以下であった。また、このコポリマー
の重量平均分子量は約84万であった。
Reference example (manufacture of polymer) Reference example 1 Deionized water 2 was placed in a nitrogen-substituted closed reaction vessel equipped with a stirrer.
After charging 36.1 parts by weight and adjusting the inside of the reactor to 80°C, 1.2 parts by weight of ammonium persulfate was added, and then 85 parts by weight of the following monomer mixture EA and 15 parts by weight of MAA were added over 8 hours. While maintaining the inside of the reactor at 80° C., stirring was continued for an additional 8 hours to complete the reaction. The solid content of this dispersion was 30%, and analysis of residual monomers by gas chromatography revealed that EA was 37 ppm and M
AA was 10 ppm or less. Moreover, the weight average molecular weight of this copolymer was about 840,000.

参考例 2 窒素置換した攪拌機付密閉型反応容器に、脱イオン水2
37.3重量部およびイソプロパツール0.5重量部を
仕込んで反応器内を80℃に調節したのち過硫酸アンモ
ニウム1.7重量部を添加し、ついで下記のモノマー混
合物 EA     85重量部 MAA    15重量部 を5時間にわたって添加した0反応器内を85℃に維持
し、過酸化水素、硫酸第一鉄及びL−アスコルビン酸を
0.1重量部添加し5時間攪拌を続は反応を完結させた
。この分散液の固形分は30%で、ガスクロマトグラフ
ィーによる残存モノマー混合物の結果、EAは12pp
mでMAAは10 ppm以下であった。また、このコ
ポリマーの重量平均分子量は約18万であった。
Reference example 2 Deionized water 2 was added to a closed reaction vessel equipped with a stirrer and replaced with nitrogen.
After charging 37.3 parts by weight and 0.5 parts by weight of isopropanol and adjusting the temperature inside the reactor to 80°C, 1.7 parts by weight of ammonium persulfate was added, and then 85 parts by weight of the following monomer mixture EA and 15 parts by weight of MAA were added. The inside of the reactor was maintained at 85°C, and 0.1 parts by weight of hydrogen peroxide, ferrous sulfate and L-ascorbic acid were added and stirred for 5 hours to complete the reaction. . The solids content of this dispersion was 30%, and the residual monomer mixture by gas chromatography showed an EA of 12 pp.
MAA was below 10 ppm. Moreover, the weight average molecular weight of this copolymer was about 180,000.

参考例 3 窒素置換した攪拌機付密閉型反応容器に、脱イオン水2
37.3重量部およびイソプロパツール2.0重量部を
仕込んで反応器内を80°Cに調節したのち過硫酸アン
モニウム1.7重量部を添加し、ついで下記のモノマー
混合物 EA     80重量部 MAA    20重量部 を8時間にわたって添加した0反応器内を85℃に維持
し、過酸化水素、硫酸第一鉄及びL−アスコルビン酸を
0.1重量部添加し5時間攪拌を続は反応を完結きせた
。この分散液の固形分は30%で、ガスクロマトグラフ
ィーによる残存モノマーの分析の結果、EAは20pp
mでMAAは10 ppm以下であった。また、このコ
ポリマーの重量平均分子量は約13万であった。
Reference example 3 Deionized water 2.
After charging 37.3 parts by weight and 2.0 parts by weight of isopropanol and adjusting the temperature inside the reactor to 80°C, 1.7 parts by weight of ammonium persulfate was added, and then the following monomer mixture EA 80 parts by weight MAA 20 The inside of the reactor was maintained at 85°C, and 0.1 parts by weight of hydrogen peroxide, ferrous sulfate and L-ascorbic acid were added and stirred for 5 hours until the reaction was completed. Ta. The solid content of this dispersion was 30%, and as a result of analysis of residual monomers by gas chromatography, the EA was 20 pp.
MAA was below 10 ppm. Moreover, the weight average molecular weight of this copolymer was about 130,000.

参考例 4 窒素置換した攪拌機付密閉型反応容器に、脱イオン水2
38.0重量部およびイソプロパツール3.0重量部を
仕込んで反応器内を80℃に調節したのち過硫酸アンモ
ニウム2.0重量部を添加し、ついで下記のモノマー混
合物 EA     75重量部 MAA    25重量部 を5時間にわたって添加した0反応器内を85℃に維持
し、過酸化水素、硫酸第一鉄及びL−アスコルビン酸を
0.1重量部添加し5時間攪拌を続は反応を完結させた
。この分散液の固形分は30%で、ガスクロマトグラフ
ィーによる残存モノマーの分析の結果、EAは18pp
mでMAAは10 ppm以下であった。また、このコ
ポリマーの重量平均分子量は約11万であった。
Reference example 4 Deionized water 2.
After charging 38.0 parts by weight and 3.0 parts by weight of isopropanol and adjusting the temperature inside the reactor to 80°C, 2.0 parts by weight of ammonium persulfate was added, and then 75 parts by weight of the following monomer mixture EA and 25 parts by weight of MAA were added. The inside of the reactor was maintained at 85°C, and 0.1 parts by weight of hydrogen peroxide, ferrous sulfate and L-ascorbic acid were added and stirred for 5 hours to complete the reaction. . The solid content of this dispersion was 30%, and as a result of analysis of residual monomers by gas chromatography, the EA was 18 pp.
MAA was below 10 ppm. Moreover, the weight average molecular weight of this copolymer was about 110,000.

参考例 5 窒素置換した攪拌機付密閉型反応容器に、脱イオン水2
37.3重量部を仕込んで反応器内を80℃に調節した
のち過硫酸カリウム1.7重量部を添加し、ついで下記
のモノマー混合物EA     85重量部 MAA    15重量部 を8時間にわたって添加した0反応器内を80°Cに維
持し過酸化水素、硫酸第一鉄及びL−アスコルビン酸を
0.1重量部添加し5時間攪拌を続は反応を完結させた
。この分散液の固形分は30%で、ガスクロマトグラフ
ィーによる残存モノマーの分析の結果、EAは15pp
mでMAAは10ppm以下であった。また、このコポ
リマーの重量平均分子量は約75万であった。
Reference example 5 Deionized water was poured into a sealed reaction vessel with a stirrer and replaced with nitrogen.
After charging 37.3 parts by weight and adjusting the inside of the reactor to 80°C, 1.7 parts by weight of potassium persulfate was added, and then 85 parts by weight of the following monomer mixture EA and 15 parts by weight of MAA were added over 8 hours. The inside of the reactor was maintained at 80° C., hydrogen peroxide, ferrous sulfate, and L-ascorbic acid were added in an amount of 0.1 part by weight, and the reaction was continued with stirring for 5 hours to complete the reaction. The solid content of this dispersion was 30%, and as a result of analysis of residual monomers by gas chromatography, the EA was 15 pp.
MAA was 10 ppm or less. Moreover, the weight average molecular weight of this copolymer was about 750,000.

参考例 6゛ 窒素置換した攪拌機付密閉型反応容器に、脱イオン水1
87.8重量部を仕込んで反応器内を75℃に調節した
のち過硫酸アンモニウム1.1重量部を添加し、ついで
下記のモノマー混合物EA     80重量部 MAA    20℃量部 を5時間にわたって添加した0反応器内を88℃に維持
し過酸化水素、硫酸第一鉄及びL−アスコルビン酸を0
.1重量部添加し5時間攪拌を続は反応を完結させた。
Reference example 6. In a closed reaction vessel equipped with a stirrer and replaced with nitrogen, add 1 part of deionized water.
After charging 87.8 parts by weight and adjusting the temperature inside the reactor to 75°C, 1.1 parts by weight of ammonium persulfate was added, and then 80 parts by weight of the following monomer mixture EA and parts by weight of MAA at 20°C were added over 5 hours. The temperature inside the reactor was maintained at 88°C, and hydrogen peroxide, ferrous sulfate, and L-ascorbic acid were reduced to zero.
.. After adding 1 part by weight and stirring for 5 hours, the reaction was completed.

この分散液の固形分は35%で、ガスクロマトグラフィ
ーによる残存モノマーの分析の結果、EAは15ppm
でMAAは10ppm以下であった。また、このコポリ
マーの重量平均分子量は約80万であった。
The solid content of this dispersion was 35%, and as a result of analysis of residual monomers by gas chromatography, the EA was 15 ppm.
The MAA was 10 ppm or less. Moreover, the weight average molecular weight of this copolymer was about 800,000.

参考例 7 窒素置換した攪拌機付密閉型反応容器に、脱イオン水1
51.7重量部を仕込んで反応器内を70℃に調節した
のち過硫酸アンモニウム1.1重置部を添加し、ついで
下記のモノマー混合物EA     85重量部 MAA    15重量部 を8時間にわたって添加した0反応器内をgo’cに維
持し過酸化水素、硫酸第一鉄及びL−アスコルビン酸を
0.1重量部添加し5時間攪拌を続は反応を完結させた
。この分散液の固形分は40%で、ガスクロマトグラフ
ィーによる残存上ツマ−の分析の結果、EAは20pp
mでMAAは10ppca以下であった。また、このフ
ポリマーの重量平均分子量は約118万であった。
Reference example 7 In a closed reaction vessel equipped with a stirrer and replaced with nitrogen, add 1 part of deionized water.
After charging 51.7 parts by weight and adjusting the temperature inside the reactor to 70°C, 1.1 parts by weight of ammonium persulfate was added, and then 85 parts by weight of the following monomer mixture EA and 15 parts by weight of MAA were added over 8 hours. While maintaining the inside of the reactor at GO'C, 0.1 parts by weight of hydrogen peroxide, ferrous sulfate and L-ascorbic acid were added and stirred for 5 hours to complete the reaction. The solid content of this dispersion was 40%, and as a result of gas chromatography analysis of residual sulfur, the EA was 20 pp.
MAA was less than 10 ppca at m. Moreover, the weight average molecular weight of this fupolymer was about 1,180,000.

実施例 1 参考例1で調製した分散液をポリマーとして50gにな
るよう適当な容器に重量する。イソプロパツール(以下
、IFと言うこともある)658gを加えて、ポリマー
が完全に溶解するまで攪拌する。該ポリマーの溶液にエ
チルセルロース(以下、ECと言うこともある)10g
を徐々に加えて、均一な分散液を調製し、水を加えて全
量を1kgとする0本組成物は参考例1のポリマー5.
0%およびEC1,0%をIP中に含有する。
Example 1 The dispersion prepared in Reference Example 1 was weighed as 50 g as a polymer into a suitable container. Add 658 g of isopropanol (hereinafter sometimes referred to as IF) and stir until the polymer is completely dissolved. Add 10 g of ethyl cellulose (hereinafter sometimes referred to as EC) to the polymer solution.
was gradually added to prepare a uniform dispersion, and water was added to make a total amount of 1 kg.This composition was prepared using Polymer 5. of Reference Example 1.
0% and EC 1,0% in the IP.

実施例 2 参考例2で調製したポリマーを用いて、実施例1の調製
方法にしたがって、ポリマー5.0%およびEC1,0
%を含む含水IP浴溶液調製する。
Example 2 Using the polymer prepared in Reference Example 2, according to the preparation method of Example 1, polymer 5.0% and EC 1.0
Prepare a water-containing IP bath solution containing %.

実施例 3 参考例3で調製したポリマーを用いて、実施例1の調製
方法にしたがって、ポリマー5.0%およびEC1,0
%を含む含水IP浴溶液調製す′る。
Example 3 Using the polymer prepared in Reference Example 3, according to the preparation method of Example 1, polymer 5.0% and EC 1.0
Prepare a water-containing IP bath solution containing %.

実施例 4 参考例4で調製したポリマーを用いて、実施例1の調製
方法にしたがって、ポリマー5.0%およびEC1,0
%を含む含水IP浴溶液調製する。
Example 4 Using the polymer prepared in Reference Example 4, according to the preparation method of Example 1, polymer 5.0% and EC 1.0
Prepare a water-containing IP bath solution containing %.

実施例 5 参考例1で調製したポリマーを用いて、実施例1の調製
方法にしたがって、ポリマー3.5%およびEC1,0
%を含む含水IF溶涜を調製する。
Example 5 Using the polymer prepared in Reference Example 1, according to the preparation method of Example 1, polymer 3.5% and EC 1.0
Prepare a hydrous IF solution containing %.

実施例 6 参考例1で調製したポリマーを用いて、実施例1の調製
方法にしたがって、ポリマー7.0%およびEC1,0
%を含む含水IF浴溶液調製する。
Example 6 Using the polymer prepared in Reference Example 1, according to the preparation method of Example 1, polymer 7.0% and EC 1.0
Prepare a water-containing IF bath solution containing %.

実施例 7 参考例1で調製したポリマーを用いて、実施例1の調製
方法にしたがって、ポリマー・10.0%およびEC1
,0%を含む含水IF浴溶液調製する。
Example 7 Using the polymer prepared in Reference Example 1, according to the preparation method of Example 1, polymer 10.0% and EC1
, prepare a water-containing IF bath solution containing 0%.

実施例 8 参考例2で調製したポリマーを用いて、実施例1の調製
方法にしたがって、ポリマー7.0%およびEC1,0
%を含む含水IF浴溶液調製する。
Example 8 Using the polymer prepared in Reference Example 2, according to the preparation method of Example 1, polymer 7.0% and EC 1.0
Prepare a water-containing IF bath solution containing %.

試験例 1 以下の組成物を人の手の甲に塗布して、本発明組成物の
性能を検討した。対照として、本発明ポリマーのEC無
添加組成物、公知のアクリル系ポリマーによる組成物、
および市販の液状絆創膏を用いた。結果を表1に示す。
Test Example 1 The following composition was applied to the back of a person's hand to examine the performance of the composition of the present invention. As a control, an EC-free composition of the polymer of the present invention, a composition of a known acrylic polymer,
and a commercially available liquid bandage. The results are shown in Table 1.

(被験組成物) 本発明組成物 実施例1〜7 対照組成物(先行技術) 参考1 含水IF中に以下の成分を含む。(Test composition) Composition of the present invention Examples 1-7 Control composition (prior art) Reference 1 The following components are contained in the hydrated IF.

参考例1のポリマー  3.5% 参考2 含水IF中に以下の成分を含む。Polymer of Reference Example 1 3.5% Reference 2 The following components are contained in the hydrated IF.

参考例1のポリマー  5.0% 参考3 含水tp中に以下の成分を含む。Polymer of Reference Example 1 5.0% Reference 3 The water-containing TP contains the following components.

参考例1のポリマー  7.0% 参考4 含水IF中に以下の成分を含む。Polymer of Reference Example 1 7.0% Reference 4 The following components are contained in the hydrated IF.

参考例1のポリマー 10.0% 対照l 含水IF中、に以下の成分を含む。Polymer of Reference Example 1 10.0% Control l The hydrated IF contains the following components:

オイドラギットE30D   5.0%EC1,0% 対照2 含水IF中に以下の成分を含む。Eudragit E30D 5.0%EC1.0% Control 2 The following components are contained in the hydrated IF.

オイドラギットE30D   10 、0%ECl、Q
% 対照3 含水IF中に以下の成分を含む。
Eudragit E30D 10, 0% ECl, Q
% Control 3 Contains the following components in hydrated IF.

オイドラギy トL30D−5510、0%EC1,0
% 対照4 市販の被膜形成剤(エアゾル型) 対照5 市販の液状絆創膏 級3 本発明の皮膚保護剤は、公知のアクリル系ポリマーを使
用した皮膚保護剤や市販の液状絆創膏と比べて、明らか
により高い官能特性を示した。玄た、セルロースの添加
により、塗布時の粘着性及び乾燥後の伸縮性が改善され
た。
Eudragi y To L30D-5510, 0%EC1,0
% Control 4 Commercially available film forming agent (aerosol type) Control 5 Commercially available liquid adhesive bandage grade 3 The skin protective agent of the present invention is clearly more effective than skin protective agents using known acrylic polymers and commercially available liquid adhesive plasters. It showed high sensory properties. The addition of brown sugar and cellulose improved the tackiness during application and the elasticity after drying.

試験例 2 健常成人7名に対して、皮膚保護剤使用時の官能試験を
行なった。以下に試験方法を記載する。
Test Example 2 A sensory test was conducted on 7 healthy adults while using the skin protectant. The test method is described below.

(検体の塗布方法) 下記の基準に従って、基準検体を右手に、試験検体を左
手に塗布する。
(Method of applying the specimen) Apply the reference specimen to the right hand and the test specimen to the left hand according to the following criteria.

1、基準検体を右手の甲に5滴(約100mg)滴下す
る。
1. Drop 5 drops (approximately 100 mg) of the reference specimen onto the back of your right hand.

2、左手指先で右手の甲中央部から母指を除く4指の第
二関節まで均等に塗り広げる。
2. Use the fingertips of your left hand to spread it evenly from the center of the back of your right hand to the second joints of all four fingers, excluding the thumb.

3、試験検体を左手の甲に5滴(約100a+g)滴下
する。
3. Drop 5 drops (approximately 100a+g) of the test specimen onto the back of your left hand.

4、右手指先で左手の甲中央部から母指を除く4指の第
二関節まで均等に塗り広げる。
4. Using the fingertips of your right hand, spread it evenly from the center of the back of your left hand to the second joints of all four fingers, excluding the thumb.

s、m布置後の評価を行なう。Evaluate after placing s and m.

6、滴下10分後に検体乾燥後の評価を行なう。6. Evaluate the specimen after drying 10 minutes after dropping.

7、続いて水使用時の評価を行なう。7. Next, evaluate when using water.

8.70%エタノールで検体を拭い取る。8. Wipe the specimen with 70% ethanol.

9、前記項目を1クールとして、1日3回評価を行なう
、但し、1回の評価後から次の評価までは3時間以上あ
ける。
9. The above items are considered to be one course, and evaluations are conducted three times a day. However, there should be at least 3 hours between each evaluation and the next evaluation.

(評価項目および評価基準) [評価項目] 1星皇麗 1、塗り広げ易さ 2、ネバネバ感 3、乾き易さ 4、!!!布直後直後合評価 灸燥菫 5、被膜の艶 6、被膜の滑らかさ 7、剥がれ難さ 8、皮膚のツッパリ感 9、乾燥後の総合評価 本叉旦! 10、剥がれ難き 11、ぬめり感 12、水使用時の総合評価 葭評 13、以上全体を通しての総合評価 [評価基準] 以上の各項目毎にそれぞれ下記の評点を与え、釣り合い
型不完備ブロックデザインに基づいて分散分析を行なっ
た。
(Evaluation items and evaluation criteria) [Evaluation items] 1 star Korei 1, ease of spreading 2, stickiness 3, ease of drying 4! ! ! Immediately after drying evaluation: Violet 5, gloss of film 6, smoothness of film 7, difficulty in peeling 8, skin tightness 9, overall evaluation after drying: 100%! 10, hard to peel 11, slimy feel 12, overall evaluation when using water 13, overall evaluation of the above [Evaluation criteria] The following evaluation was given for each of the above items, and the balanced incomplete block design An analysis of variance was performed based on the results.

正A 悪いニー2、やや悪いニー1、同じ:0、やや良い:+
1、良い:+2゜ 以上述べた試験方法に従って、下記組成物について官能
性を比較した。結果を表2に示すが、以下の表中に示さ
れる評価数値は、0より大きければ基準検体より高い評
価を、0より小さければ低い評価であることを示す。
Correct A Bad knee 2, slightly bad knee 1, same: 0, slightly good: +
1. Good: +2° The organoleptic properties of the following compositions were compared according to the test method described above. The results are shown in Table 2, and the evaluation values shown in the table below indicate that a value greater than 0 indicates a higher evaluation than the reference specimen, and a value smaller than 0 indicates a lower evaluation.

(被験組成物) 本発明皮膚保護剤 実施例1および2 先行技術皮膚保護剤 対照組成物6 含水■P中に以下の成分を含む。(Test composition) Skin protection agent of the present invention Examples 1 and 2 Prior art skin protectant Control composition 6 Water-containing ■P contains the following ingredients.

オイドラギットE30D   3.5%EC1,5% 対照組成物7 含水IP中に以下の成分を含む。Eudragit E30D 3.5% EC1.5% Control composition 7 Water-containing IP contains the following ingredients.

オイドラギットL30D−555,0%プロピレングリ
コール   1.0% 表2 液玉 本発明の皮膚保護剤は、公知のアクリル系ポリマーを使
用した皮膚保護剤と比べて、より高い官能特性を示した
Eudragit L30D-555.0% Propylene Glycol 1.0% Table 2 Liquid Balls The skin protectant of the present invention exhibited higher organoleptic properties compared to skin protectants using known acrylic polymers.

試験例 3 試験例2記載の方法に従って、皮膚保護剤におけるポリ
マーの好適濃度を調べた。表3に結果を示す。
Test Example 3 According to the method described in Test Example 2, the preferred concentration of the polymer in the skin protective agent was investigated. Table 3 shows the results.

(被験組成物) 実施例2:ポリマー 5.0% 実施例8:ポリマー 7.0% (以下余白) 表3 1   0.458  0.167 2   0.025 −0.267 3   0.000  0.125 4   0.300 −0.117 5   1.000  0.292 60.20g  −0,167 70,008−0,033 80,733−0,017 90,442−0,183 10−0,192−0,108 11−0,158−0,200 ポリマー濃度は、5%が好適であった。(Test composition) Example 2: Polymer 5.0% Example 8: Polymer 7.0% (Margin below) Table 3 1 0.458 0.167 2 0.025 -0.267 3 0.000 0.125 4 0.300 -0.117 5 1.000 0.292 60.20g -0,167 70,008-0,033 80,733-0,017 90,442-0,183 10-0,192-0,108 11-0,158-0,200 A suitable polymer concentration was 5%.

[発明の効果] 本発明のアクリル系ポリマーを主体とする皮膚保護剤は
、先行技術のいずれのものより安全性が高く、使用感の
良い皮膚保護剤であることが確認された。本発明皮膚保
護剤は、極少量を皮膚に塗布することにより、極めて薄
い被膜を形成する。
[Effects of the Invention] It was confirmed that the skin protection agent based on the acrylic polymer of the present invention is safer than any of the prior art skin protection agents and has a good feeling of use. The skin protective agent of the present invention forms an extremely thin film by applying a very small amount to the skin.

形成された被膜は充分に耐水性があり、伸びがあってか
つ柔軟で、皮膚に違和感を与えることなく、よく密着す
る。更に界面活性剤を含まず、残存上ツマ−の量を最低
限に抑えである為、刺激性が低く、中性洗剤などの透過
を助ぐので皮膚に対して極めて安全である。また、使用
後は石齢などの弱アルカリ溶液またはアルコールなどで
容易に除去することも出来るので、例えば家庭の主婦、
職業的な器具洗浄者、薬液使用者などに、優れた手の保
護被覆を提供することが出来る。
The formed film is sufficiently water resistant, stretchy and flexible, and adheres well to the skin without causing discomfort. Furthermore, since it does not contain a surfactant and the amount of residual dirt is kept to a minimum, it is less irritating and helps the permeation of neutral detergents, making it extremely safe for the skin. In addition, after use, it can be easily removed with a weak alkaline solution such as stone age or alcohol, so for example, housewives,
It can provide an excellent hand protection covering for professional equipment cleaners, chemical users, etc.

また、本発明皮膚保護剤を塗布する前に、適当な皮膚外
用剤を塗布しておけば、液状絆創膏あるいはODT療法
の保護膜としても利用可能で、例えば、手、膝、首すじ
、顔面等、伸縮の激しい個所には、特に好適である。
In addition, if a suitable external skin preparation is applied before applying the skin protection agent of the present invention, it can be used as a liquid bandage or a protective film for ODT therapy.For example, it can be used on the hands, knees, neck, face, etc. It is particularly suitable for areas subject to severe expansion and contraction.

Claims (4)

【特許請求の範囲】[Claims] (1)実質的に下記基本成分からなる皮膚保護剤。 a、アクリル酸エチルとメタアクリル酸とのモノマー比
率が75/25から95/5の範囲内にあつて、残存モ
ノマーが50ppm以下であり、実質的に界面活性剤を
含まないアクリル系ポリマー約2〜10%、 b、セルロース誘導体約0.2〜2%および、c、含水
アルコール残余量
(1) A skin protective agent consisting essentially of the following basic ingredients. a, an acrylic polymer in which the monomer ratio of ethyl acrylate and methacrylic acid is within the range of 75/25 to 95/5, the residual monomer is 50 ppm or less, and substantially does not contain a surfactant. ~10%, b. Approximately 0.2-2% of cellulose derivative, and c. Residual amount of hydroalcohol.
(2)前記アクリル系ポリマーの重量平均分子量が約1
0万〜約130万である特許請求の範囲第1項記載の皮
膚保護剤。
(2) The weight average molecular weight of the acrylic polymer is about 1
The skin protective agent according to claim 1, which has a molecular weight of 0,000 to about 1,300,000.
(3)前記セルロース誘導体がエチルセルロースである
特許請求の範囲第1項記載の皮膚保護剤。
(3) The skin protective agent according to claim 1, wherein the cellulose derivative is ethylcellulose.
(4)前記アルコールがエタノールまたはイソプロパノ
ールである特許請求の範囲第1項記載の皮膚保護剤。
(4) The skin protective agent according to claim 1, wherein the alcohol is ethanol or isopropanol.
JP61253071A 1986-10-23 1986-10-23 Skin protecting agent Granted JPS63104909A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP61253071A JPS63104909A (en) 1986-10-23 1986-10-23 Skin protecting agent
CA000548194A CA1299319C (en) 1986-10-23 1987-09-29 Acrylic copolymer and skin protective
NZ222096A NZ222096A (en) 1986-10-23 1987-10-08 Skin protective agent comprising copolymer of ethyl acrylate and methacrylic acid
US07/109,619 US4874830A (en) 1986-10-23 1987-10-19 Acrylic copolymer and skin protective
ES198787309265T ES2031909T3 (en) 1986-10-23 1987-10-20 ACRYLIC COPOLYMER, SKIN PROTECTIVE COMPOSITION AND ITS USE.
EP19870309265 EP0265228B1 (en) 1986-10-23 1987-10-20 Acrylic copolymer and skin protective and their use
AT87309265T ATE76286T1 (en) 1986-10-23 1987-10-20 ACRYLIC COPOLYMERS, SKIN PROTECTION AGENTS CONTAINING THEM AND THEIR APPLICATION.
DE8787309265T DE3779250D1 (en) 1986-10-23 1987-10-20 ACRYLCOPOLYMERS, THESE SKIN PROTECTORS AND THEIR USE.
KR1019870011752A KR950011449B1 (en) 1986-10-23 1987-10-22 Acrylic copolymer and skin protective
AU80088/87A AU602731B2 (en) 1986-10-23 1987-10-23 Acrylic copolymer and skin protective
US07/353,818 US4914140A (en) 1986-10-23 1989-05-18 Acrylic copolymer and skin protective
GR920401234T GR3004890T3 (en) 1986-10-23 1992-06-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61253071A JPS63104909A (en) 1986-10-23 1986-10-23 Skin protecting agent

Publications (2)

Publication Number Publication Date
JPS63104909A true JPS63104909A (en) 1988-05-10
JPH029006B2 JPH029006B2 (en) 1990-02-28

Family

ID=17246086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61253071A Granted JPS63104909A (en) 1986-10-23 1986-10-23 Skin protecting agent

Country Status (1)

Country Link
JP (1) JPS63104909A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923893A (en) * 1987-12-08 1990-05-08 Shionogi & Co., Ltd. External preparation of vitamin-E
KR100335256B1 (en) * 1998-06-15 2002-05-03 조지안느 플로 Cosmetic composition containing a cationic polymer and an acrylic terpolymer, and use of this composition for the treatment of keratinous material
KR100335258B1 (en) * 1998-06-15 2002-05-03 조지안느 플로 Cosmetic composition containing a polysaccharide and an acrylic terpolymer, and use of this composition for the treatment of keratinous material
JP2008100966A (en) * 2006-10-20 2008-05-01 Kyowa Ltd Skin protecting agent
WO2020110325A1 (en) * 2018-11-27 2020-06-04 英昌化学工業株式会社 Spray for forming protective film on skin surface

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923893A (en) * 1987-12-08 1990-05-08 Shionogi & Co., Ltd. External preparation of vitamin-E
KR100335256B1 (en) * 1998-06-15 2002-05-03 조지안느 플로 Cosmetic composition containing a cationic polymer and an acrylic terpolymer, and use of this composition for the treatment of keratinous material
KR100335258B1 (en) * 1998-06-15 2002-05-03 조지안느 플로 Cosmetic composition containing a polysaccharide and an acrylic terpolymer, and use of this composition for the treatment of keratinous material
JP2008100966A (en) * 2006-10-20 2008-05-01 Kyowa Ltd Skin protecting agent
WO2020110325A1 (en) * 2018-11-27 2020-06-04 英昌化学工業株式会社 Spray for forming protective film on skin surface

Also Published As

Publication number Publication date
JPH029006B2 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
JP4708570B2 (en) Non-irritating coating composition
US4914140A (en) Acrylic copolymer and skin protective
TW590776B (en) Antipsoriatic nail polish
JP5468374B2 (en) External preparation for fingers
CA2004049C (en) Topical application of medicament in a binder
JP4887112B2 (en) Skin protectant
JPS63104909A (en) Skin protecting agent
JP2740542B2 (en) Skin protection composition
JP3212637B2 (en) Film-type skin protectant
JPS63108013A (en) Polymer for skin protection
JPH09194337A (en) Hair cosmetic
JP2539247B2 (en) Hair cosmetics
JP4129940B2 (en) Hair cosmetics using a base for hair cosmetics
JPS5939825A (en) Base composition for external use
JPH09249722A (en) Hairdressing resin composition
JP2938325B2 (en) Peelable skin protectant
JP3414493B2 (en) Hairdressing base
JPS6229516A (en) Pharmaceutical preparation
JPH0797317A (en) Film-forming agent for external use
JPH11116459A (en) Composition for body
TW202313114A (en) gel composition
JP2596549B2 (en) Method for producing resin for hair styling
TW202312983A (en) gel composition
JP2003212718A (en) Composition for body treatment
JPH0331165B2 (en)

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term